Ohr Pharmaceutical Inc (37) | Bonus & Incentive Agreements (3)
- Form of Option Agreement under NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- Retention Bonus Agreement, by and between Ohr Pharmaceutical, Inc. and Dr. Jason Slakter (Filed With SEC on January 3, 2019)
